Real world effectiveness of Mycophenolate-sodium therapy in patients at risk with Graves' orbitopathy. [PDF]
Sander J +6 more
europepmc +1 more source
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study. [PDF]
Hötte GJ +10 more
europepmc +1 more source
Safety of different types of methylprednisolone puls-therapy in the treatment of Graves' orbitopathy
Olga Vinogradskaya +2 more
openalex +1 more source
Risk factors and outcomes of Graves' orbitopathy after radioactive iodine therapy. [PDF]
Ahn HY, Lee J, Kim M, Lee JK.
europepmc +1 more source
Retraction: Preliminary Evidence From an Original Study Suggests Combustion, Not Nicotine, Drives Risk and Complications of Graves' Orbitopathy. [PDF]
Acanfora M, Vassallo A.
europepmc +1 more source
Impact of immunosuppressive states on Graves’ orbitopathy: Case report and literature review
Samir Cayenne, Ahsen Hussain
openalex +1 more source
Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells [PDF]
Sven Brandau +8 more
openalex +1 more source
Age-dependent diagnostic and treatment response prediction of TBII and TSI in Graves' orbitopathy: integration with orbital MRI biomarkers. [PDF]
Song C +11 more
europepmc +1 more source
Unilateral Graves' Orbitopathy Followed by Hashimoto's Hypothyroidism: Highlighting Micronutrient Influence in Thyroid Autoimmunity. [PDF]
Kermaj M +4 more
europepmc +1 more source

